BIOXYTRAN, INC Stock Agreements
6 Contracts & Agreements
- Certificate of Designation of Convertible Preferred Stock, dated April 19, 2024 (Filed With SEC on April 19, 2024)
- Option Agreement for conversion/exchange between Pharmalectin, Inc. and Bioxytran, Inc. shares of Common Stock, dated November 20, 2021 (Filed With SEC on April 19, 2024)
- 2017 Employee, Director and Consultant Stock Plan (Subsidiary), adopted by the Board of Directors on October 5, 2017 (Filed With SEC on June 24, 2021)
- 2021 Employee, Director and Consultant Stock Plan, adopted by the Board of Directors on January 19, 2021 (Filed With SEC on June 24, 2021)
- Form of Common Stock Certificate (Filed With SEC on February 1, 2019)
- Form of Common Stock Certificate (Filed With SEC on January 30, 2019)
